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To the Editor:
This issue of J Hum Growth Dev contains 
an excellent review by Pérez-Riera et al1 
describing one of the most involved ion channel 
gene named SCN5A that encoded the cardiac 
sodium channel linked to different inherited 
cardiac arrhythmias (ICA) phenotypes or/and 
syndromes. The genetic bases of mutation in 
the SCN5A gene has been implicated in ICA 
phenotypes and their functional impact may 
lead to a signifi cant loss (reduction) or gain 
(increasing) of the sodium channels mutants 
compared with the wild type. 
Sodium channelopathies are recently 
delineated, emerging as a group of ICA 
disorders grouped by genetically determined 
defects in ion-channel function. ICA disorders 
are characterized by a prominent genetic and 
phenotypic heterogeneity that can make them 
challenging to understand. This systematic 
review by Pérez-Riera et al (1) attempts to 
understand the role of the sodium channel 
mutations of these disorders according to 
their clinical manifestations (i.e., Long QT 
Syndrome, Brugada Syndrome and others), 
within the context of what is presently known 
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and their molecular and genetic basis. The 
review is intended to assist clinicians and 
scientists in enhancing their clinical and genetic 
diagnostic knowledge. 
The functional genomics in vitro studies 
are part of the new process to be translated into 
potential treatments to restore the dysfunction 
cardiac electrophysiology linked within 
mutations in the SCN5A gene2. The new 
generation of DNA sequencing methods has 
now discovered hundreds of new mutations 
in different sodium channels genes that can 
lead different phenotypes of channelopathies; 
and the majority are located in the SCN5A 
gene showing low expression in the adult 
heart system. Our group and others found new 
mutations in the β3 subunits associated with 
Brugada syndrome and cardiac conduction 
disease with a signifi cant reduction in the peak 
sodium current by the co-interaction with the 
mutant β subunits and SCN5A channels3. 
Pérez-Riera et al; described in this review 
that different mutations in SCN5A may lead a large 
spectrum of different arrhythmia phenotypes1. 
For this reason, it is very important to develop 
new innovative studies in pharmacogenomics 
to determine the best treatment options to be 
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used as specifi c antiarrhythmic drugs (AAD) in 
all different ICA phenotypes or syndromes. The 
majority of the AAD agents that act as blockers 
have receptor sites on the alpha subunits in the 
sodium channel protein structure. (4) There 
are some ADD that shown a positive result by 
rescuing the loss of function in some SCN5A 
mutations. For example, the I1660V mutation 
that produced a signifi cant reduction in sodium 
current  can be treated by using some sodium 
channel blockers that can rescue the I1660V 
mutant sodium current (mexiletine, ranolazine, 
ajmaline, quinidine). Mexiletine has proved to 
be the most effective.5 In the modeling site of 
sodium channels; the L325R mutation showed 
in cardiac action potential experiments in 
patients with reduced sodium channels and 
fever; conditions that could prematurely shorten 
the action potential, suggesting that a dominant 
negative phenomenon may underlie BrS 
triggered by fever. (6) On the other hand, some 
other AAD are used to unmask other diseases 
such as BrS. 
We are very grateful to read the integration 
of the basic and translational description of this 
review by Perez-Riera et al; which contributes 
to knowledge translation in this fascinating are 
of science. 
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